Navigation Links
Gastrointestinal Disorders Therapeutics to 2016 - High Unmet Needs Triggering Strong Growth in Crohn's Disease and Irritable Bowel Syndrome Markets Now Available at ReportsandReports
Date:6/28/2010

Disorder Therapeutics Market, Global, Usage Patterns, 2009-2016 21

Table 15: Gastrointestinal Disorder Therapeutics Market, The US, Revenue ($bn), 2001-2009 22

Table 16: Gastrointestinal Disorder Therapeutics Market, The US, Revenue ($bn), 2009-2016 22

Table 17: Gastrointestinal Disorder Therapeutics Market, The US, Annual Cost of Treatment , 2001-2009 23

Table 18: Gastrointestinal Disorder Therapeutics Market, The US, Annual Cost of Treatment, 2009-2016 23

Table 19: Gastrointestinal Disorder Therapeutics Market, The US, Diseased Population, 2001-2009 24

Table 20: Gastrointestinal Disorder Therapeutics Market, The US, Diseased Population, 2009-2016 24

Table 21: Gastrointestinal Disorder Therapeutics Market, The US, Treatment Seeking Population, 2001-2009 25

Table 22: Gastrointestinal Disorder Therapeutics Market, The US, Treatment Seeking Population, 2009-2016 25

Table 23: Gastrointestinal Disorder Therapeutics Market, The US, Diagnosis Population, 2001-2009 26

Table 24: Gastrointestinal Disorder Therapeutics Market, The US, Diagnosis Population, 2009-2016 26

Table 25: Gastrointestinal Disorder Therapeutics Market, The US, Prescription Population, 2001-2009 27

Table 26: Gastrointestinal Disorder Therapeutics Market, The US, Prescription Population, 2009-2016 27

Table 27: Gastrointestinal Disorder Therapeutics Market, The US, Usage Patterns, 2001-2009 28

Table 28: Gastrointestinal Disorder Therapeutics Market, The US, Usage Patterns, 2009-2016 29


'/>"/>
SOURCE MarketsandMarkets
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

Related biology technology :

1. Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
2. ViroPharma Provides Update on Upcoming FDA Advisory Committee Meeting to Discuss Bioequivalence of Locally Acting Gastrointestinal Drugs
3. Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery
4. DOR BioPharma Receives FDA Orphan Drug Designation for orBec(R) for the Treatment of Chronic Gastrointestinal GVHD
5. Soligenix Announces Grant of Broad European Patent for Topically Active Steroids to Treat Inflammatory Gastrointestinal Disorders
6. New Study Showed the Impact of Gastrointestinal Disorders in Patients With Parkinsons Disease
7. Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
8. TAP Pharmaceutical Products Inc. Files New Drug Application for TAK-390MR in Patients with Acid-Related Disorders
9. Synosia Announces Encouraging Results of Proof-of-Concept Clinical Trial for Epilepsy Drug rufinamide as a Treatment for Mood Disorders
10. SleepQuest Raises Awareness of Sleep Disorders
11. S*BIO Receives Orphan Drug Designation for JAK2 Inhibitor SB1518 for the Treatment of Myeloproliferative Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... the course of a day - car, phone, ... the chemical industry to turn raw materials such ... valuable chemicals that are the ingredients of life,s ... who achieved outstanding progress in driving this energy ... light instead of fossil fuels, has won the ...
(Date:9/18/2014)... CA (PRWEB) September 18, 2014 ... which include Sartorius/Biohit, Socorex, Capp, and AccuPet brand ... volumes of 100 uL or less and are ... and forensic applications. , The micropipette promotions ... quality and economic alternative products to help customers ...
(Date:9/17/2014)...  PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI ) ... & Young LLP ("EY") that it was resigning effective September ... to the Company on September 15, 2014 and reported in ... PDL has issued the following statement in response to ... inquiries on the reason for the resignation of EY.  We ...
(Date:9/17/2014)... Sept. 17, 2014 /PRNewswire/ - Oncothyreon Inc. (NASDAQ: ... offer and sell shares of its Common Stock and ... underwritten public offerings.  The Series A Convertible Preferred Stock ... Stock, provided that conversion will be prohibited if, as ... own more than 4.99% of the Common Stock then ...
Breaking Biology Technology:Using solar energy to turn raw materials into ingredients for every day life 2Major Pipette Distributor Pipette.com Announces Promotions on Sartorius/Biohit, Socorex, Capp, and AccuPet Micropipettes 2Major Pipette Distributor Pipette.com Announces Promotions on Sartorius/Biohit, Socorex, Capp, and AccuPet Micropipettes 3PDL BioPharma Issues Statement on Resignation of Ernst and Young as Corporate Auditors 2PDL BioPharma Issues Statement on Resignation of Ernst and Young as Corporate Auditors 3Oncothyreon Announces Proposed Public Offerings 2
... Owner of PHC Consulting) hasn't felt a down economy at all. ... in the medical industry (laboratory clinical and research, physician call points, ... for revenues and Peggy attributes that growth to a strong web ... ...
... PALO ALTO, Calif., June 25 Cell Biosciences, ... systems,to life science researchers, today announced three important ... named President and Chief Executive Officer. From 1998,through ... for Molecular,Devices Corporation where he helped build the ...
... U.S. Food and Drug,Administration (FDA) Advisory Committee ... the approval of tolvaptan, Otsuka Pharmaceutical,Development & ... hyponatremia., "Otsuka is pleased that the ... tolvaptan, an investigational selective,V2-vasopressin receptor antagonist," said ...
Cached Biology Technology:Website and Blog Increase Placement for Medical Sales Recruiter - Providing Sales Winners Calling on the Hospital, Lab and Physician Call Point 2Cell Biosciences Announces New Leadership 2U.S. Food and Drug Administration Advisory Committee Recommends Approval of Tolvaptan, an Investigational Treatment for Hyponatremia 2
(Date:9/17/2014)... BELLINGHAM, Washington, USA -- "Nature has developed, very cleverly, ... we desire in optical design," said Joseph Shaw, director ... "As we explore surfaces and structures at the nanoscale, ... presented in San Diego in August during a conference ... by Shaw and Rongguang Liang of the University of ...
(Date:9/17/2014)... (Hospital del Mar Medical Research Institute) and at the ... study in eLife showing that RNA called ... of new proteins, some of which could have important ... from the instructions found in an RNA molecule. However, ... information for the synthesis of proteins, meaning it is ...
(Date:9/17/2014)... retinoblastoma protein gene are a leading cause of eye ... fruit fly eyes to unlock the secrets of this ... on the cover of the current issue of the ... researchers provide the first detailed examination of a set ... cancer gene, said Irina Pushel, MSU undergraduate and co-author. ...
Breaking Biology News(10 mins):Nature's designs inspire research into new light-based technologies 2Nature's designs inspire research into new light-based technologies 3Parts of genome without a known function may play a key role in the birth of new proteins 2Abnormal properties of cancer protein revealed in fly eyes 2
... Farmers who don,t rely on or want to minimize the ... battle against aggressive perennial weeds. In ongoing research at the ... be a worthy contender as a summer smother crop. ... The Sudangrass creates shade so photosynthesis cannot occur in the ...
... WEST LAFAYETTE, Ind. - Wheat plants found to ... in reinforcements to build up rigid defenses. Christie ... Agriculture,s Agricultural Research Service and a Purdue University associate ... by Hessian fly larvae increased production of surface waxes ...
... Bringing the power of synchrotron light to Minnesota,s ... of a Memorandum of Agreement (MOA) signed today between ... synchrotron facility, the Canadian Light Source (CLS). ... and product outcomes while improving operating efficiency for both ...
Cached Biology News:Sudangrass recommended to combat Canada thistle 2Sudangrass recommended to combat Canada thistle 3Resistant wheat rebuilds cell walls when attacked by Hessian flies 2BioBusiness Alliance, Canadian Light Source Synchrotron sign agreement 2